Abstract:
The present invention relates to a compound which can be used in the treatment of infections caused by SARS coronaviruses, e.g. by blocking the active site of the proteases 3CLpro and PLpro. The compound can be used as inhibitor or label as such or can be used in screening methods for profiling other inhibitors. Moreover, the present invention relates to a method of producing the compound.
Abstract:
The present invention relates to hyper-branched compounds, a method of synthesizingthe hyper-branched compounds and applications of the hyper-branched compounds. Thehyper-branched compounds of the present invention include hyper-branched fluorinatedcompounds, hyper-branched fluorinated graphene and hyper-branched aminefunctionalized graphene oxide.
Abstract:
Compounds of general formula I, and the salts and solvates thereof, wherein R1 represents the radical 2-benzoylphenylamino; R2 represents -(CH 2 ) s -N(COR 3 )-A-J-T or -(CH 2 ) S -N(R 4 )-B-J-T; and s, R3, R4, A, B, J and T have the meanings disclosed in the description. These compounds are PPARγ modulators and, therefore, are useful for the treatment or prevention of a condition or a disease mediated by these receptors.
Abstract:
The present invention relates to a compound according to Formula (I) wherein R1 is a hydrocarbyl group selected from the group consisting of alkyl, alkenyl, aryl, aralkyl, and alkylaryl groups, and one or more combinations thereof; wherein R2 is a hydrogen atom, an aryl group or an alkyl group; and wherein R3, R4, R5 and R6, are the same or different and are each independently a hydrogen atom, a halogen atom, a cyano group, an amino group, a hydrocarbyl group selected from the group consisting of alkyl, alkenyl, aryl, aralkyl, and alkylaryl groups or an alkoxy group, and one or more combinations thereof as internal electron donor and to a process for the synthesis of a compound according to Formula (I), wherein R1 is a hydrocarbyl group selected from the group consisting of alkyl, alkenyl, aryl, aralkyl, alkoxycarbonyl and alkylaryl groups, and one or more combinations thereof; wherein R2 is a hydrogen atom or an alkyl group; wherein R3, R4, R5 and R6, are the same or different and are each independently selected from a group consisting of a hydrogen atom; a hydrocarbyl, preferably, said process comprising the step of reacting a compound according to Formula (II) [R1- C(=O)Cl] with a compound according to Formula (III) to obtain the compound according to Formula (I) and to the use of these compounds as internal donor in Ziegler-Natta catalysis of olefins.
Abstract:
Compounds of formula (I): wherein X, R 2 , R 3 , R 5 and R 6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
Abstract:
The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, methods of treatment administering these compounds to mammalian hosts, and processes for their preparation. Specifically, the invention relates to a means to enhance insulin-dependent glucose uptake. More specifically, the invention concerns compounds and pharmaceutical compositions that activate the insulin receptor kinase, which leads to increased sensitivity to insulin and an increase in glucose uptake, as well as processes for the preparation of the compounds. The invention also specifically concerns methods for treating humans with hyperglycemia, especially for the treatment of Type II diabetes.
Abstract:
The invention provides adamantane derivatives of formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In formula (I) D represents CH2 or CH2CH2, E represents C(O)NH or NHC(O) and R represents a group of formula (I).
Abstract:
The present invention relates to a group of compounds with autophosphorylation-inhibiting activity and antibacterial activity against different bacteria, such as Staphylococcus aureusy Staphylococcus epidermidis , inter alia, and to the use of said compounds to produce antibiotics.
Abstract:
Die Erfindung betrifft Bis-phenyl-oxalamide sowie deren physiologisch verträgliche Salze. Die Erfindung betrifft Verbindungen der Formel (I), worin Rl, R2, R3, R4, R5, R6, R7, R8, m und X die angegebenen Bedeutungen haben, sowie deren physiologisch verträgliche Salze. Die Verbindungen eignen sich z.B. zur Behandlung des Diabetes.
Abstract:
Methods for selecting novel DAA analogues for a peripheral type benzodiazepine receptor were labeled with 18 F using one-step syntheses are provided. Analogues labeled with the 18 F using the one-step synthesis method are also provided. Additionally, the purification of the Br, I, C1, TsO, MsO, or R f SO 3 precursors in the compound of formula (II) by solid phase extraction is provided as is the precursor compounds of formula (II). Kit and method of use claims for comprising an effective amount of an 18 F labeled compound, and pharmaceutically acceptable salts and solvates thereof are also provided.
Abstract translation:选择用于外周型苯二氮卓受体的新型DAA类似物的方法使用一步合成用 18F标记。 还提供了使用一步合成方法用 18F标记的类似物。 另外,提供通过固相萃取来纯化式(II)化合物中的Br,I,Cl,TsO,MsO或R 1 SO 3 N 3前体 式(II)的前体化合物也是如此。 还提供了包含有效量的18 F标记化合物及其药学上可接受的盐和溶剂化物的试剂盒和使用方法。